Your browser doesn't support javascript.
loading
SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation.
Calvo-Garrido, Javier; Maffezzini, Camilla; Schober, Florian A; Clemente, Paula; Uhlin, Elias; Kele, Malin; Stranneheim, Henrik; Lesko, Nicole; Bruhn, Helene; Svenningsson, Per; Falk, Anna; Wedell, Anna; Freyer, Christoph; Wredenberg, Anna.
Affiliation
  • Calvo-Garrido J; Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden.
  • Maffezzini C; Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden.
  • Schober FA; Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden.
  • Clemente P; Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden.
  • Uhlin E; Department of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden.
  • Kele M; Department of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden.
  • Stranneheim H; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, Sweden.
  • Lesko N; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, Sweden.
  • Bruhn H; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, Sweden.
  • Svenningsson P; Department of Clinical Neuroscience, Karolinska Institutet, 171 76 Stockholm, Sweden.
  • Falk A; Department of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden.
  • Wedell A; Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 S
  • Freyer C; Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171
  • Wredenberg A; Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171
Stem Cell Reports ; 12(4): 696-711, 2019 04 09.
Article in En | MEDLINE | ID: mdl-30827875

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Differentiation / Energy Metabolism / Cellular Reprogramming / Sequestosome-1 Protein Type of study: Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Stem Cell Reports Year: 2019 Type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Differentiation / Energy Metabolism / Cellular Reprogramming / Sequestosome-1 Protein Type of study: Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Stem Cell Reports Year: 2019 Type: Article Affiliation country: Sweden